CM Life Sciences II Inc.
CMIINASDAQFinancial Services·US · USD
$10.02
+0.00 (+0.00%)
Prices as of August 7, 2026 · market closedPrice
Key statistics
Valuation
Market cap313.94M USD
Enterprise value312.76M USD
Trailing P/E0.00
Forward P/E0.00
PEG ratio0.00
Price / sales0.00
Price / book222.67
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets0.00%
Return on equity0.00%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-61.42K USD
Diluted EPS$0.00
Rev. growth (YoY)0.00%
Balance sheet
Total cash1.19M USD
Total debt0.00 USD
Debt / equity0.00
Current ratio0.03
Book value / share$0.05
Cash flow (TTM)
Operating cash flow0.00 USD
Levered free cash flow0.00 USD
Shares & price
Shares outstanding31.33M
Float21.60M
Held by institutions76.44%
Beta0.00
50-day MA$10.03
200-day MA$9.94
52-week high$10.22
52-week low$9.76
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-080.210.08−61.90%
About CM Life Sciences II Inc.
Columbus Circle Capital Corp II does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Gary Quin
- Headquarters
- New York, NY, United States
- Website
- ii.cmlifesciencesspac.com